Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Geyer JT, Subramaniyam S, Jiang Y, Elemento O, Ferry JA, de Leval L, et al. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. Hum Pathol. 2015;46(2):260-71.

Zhao Z, Chen C-, Rillahan CD, Shen R, Kitzing T, McNerney ME, et al. Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. Nat Genet. 2015;47(5):539-43.

Erratum for the Research Article: "Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia" by Y. Lim, L. Gondek, L. Li, Q. Wang, H. Ma, E. Chang, D. L. Huso, S. Foerster, L. Marchionni, K. McGovern, D. N. Watkins, C. D. Peacock, M. Levis, B. Sci Transl Med. 2015;7(295):295er6.

Mosquera J-, Varma S, Pauli C, MacDonald TY, Yashinskie JJ, Varga Z, et al. MAGI3-AKT3 fusion in breast cancer amended. Nature. 2015;520(7547):E11-2.

Ramakrishna R, Pisapia D. Recent Molecular Advances in Our Understanding of Glioma. Cureus. 2015;7(7):e287.

Greenblatt MB, Nowak JA, Quade CC, Tanasijevic M, Lindeman N, Jarolim P. Impact of a prospective review program for reference laboratory testing requests. Am J Clin Pathol. 2015;143(5):627-34.

Okada T, Sinha S, Esposito I, Schiavon G, López-Lago MA, Su W, et al. The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nat Cell Biol. 2015;17(1):81-94.

Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. Curr Opin Virol. 2015;14:116-28.

Chen EJ, Sowalsky AG, Gao S, Cai C, Voznesensky O, Schaefer R, et al. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clin Cancer Res. 2015;21(6):1273-80.

Klingler S, Guo B, Yao J, Yan H, Zhang L, Vaseva AV, et al. Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Res. 2015;75(10):2109-19.